By Andrea Petersen — 2019
Many patients with cognitive impairment have anxiety or depression, but standard treatments are difficult for people with memory issues.
Read on www.nytimes.com
CLEAR ALL
The talk will review brain imaging work on the action of psychedelics on the brain and describe the results of a clinical trial assessing psilocybin as a treatment for depression. It will also review the broader societal impact of psychedelic drug-use and discuss its implications.
1